- Home
- CDIO vs ONFO Comparison
CDIO vs ONFO Comparison
Compare CDIO & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- ONFO
- Stock Information
- Founded
- CDIO 2017
- ONFO 2018
- Country
- CDIO United States
- ONFO United States
- Employees
- CDIO N/A
- ONFO N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- ONFO Computer Software: Programming Data Processing
- Sector
- CDIO Health Care
- ONFO Technology
- Exchange
- CDIO Nasdaq
- ONFO Nasdaq
- Market Cap
- CDIO 6.4M
- ONFO 5.4M
- IPO Year
- CDIO N/A
- ONFO 2022
- Fundamental
- Price
- CDIO $4.39
- ONFO $1.31
- Analyst Decision
- CDIO Buy
- ONFO
- Analyst Count
- CDIO 1
- ONFO 0
- Target Price
- CDIO $60.00
- ONFO N/A
- AVG Volume (30 Days)
- CDIO 41.0K
- ONFO 83.7K
- Earning Date
- CDIO 08-11-2025
- ONFO 08-13-2025
- Dividend Yield
- CDIO N/A
- ONFO N/A
- EPS Growth
- CDIO N/A
- ONFO N/A
- EPS
- CDIO N/A
- ONFO N/A
- Revenue
- CDIO $19,902.00
- ONFO $9,087,118.00
- Revenue This Year
- CDIO $1,434.82
- ONFO N/A
- Revenue Next Year
- CDIO $4,661.91
- ONFO N/A
- P/E Ratio
- CDIO N/A
- ONFO N/A
- Revenue Growth
- CDIO N/A
- ONFO 65.97
- 52 Week Low
- CDIO $3.22
- ONFO $0.61
- 52 Week High
- CDIO $53.10
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- CDIO 50.34
- ONFO 61.62
- Support Level
- CDIO $4.11
- ONFO $1.25
- Resistance Level
- CDIO $4.73
- ONFO $1.42
- Average True Range (ATR)
- CDIO 0.33
- ONFO 0.14
- MACD
- CDIO 0.10
- ONFO 0.02
- Stochastic Oscillator
- CDIO 65.03
- ONFO 64.81
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.